143 related articles for article (PubMed ID: 32938570)
1. Reply to letter to the editor: The incidence and predictors of post transarterial chemoembolization variceal bleeding in hepatocellular carcinoma patients.
Lin PT; Teng W; Jeng WJ; Lin CY
J Formos Med Assoc; 2021 Jan; 120(1 Pt 3):785-786. PubMed ID: 32938570
[No Abstract] [Full Text] [Related]
2. The incidence and predictors of post transarterial chemoembolization variceal bleeding in hepatocellular carcinoma patients.
Weng F; Li X
J Formos Med Assoc; 2021 Jan; 120(1 Pt 3):783-784. PubMed ID: 32967785
[No Abstract] [Full Text] [Related]
3. The incidence and predictors of post transarterial chemoembolization variceal bleeding in hepatocellular carcinoma patients.
Lin PT; Teng W; Jeng WJ; Hsieh YC; Hung CF; Huang CH; Lui KW; Chen YC; Lin CC; Lin SM; Sheen IS; Lin CY
J Formos Med Assoc; 2020 Feb; 119(2):635-643. PubMed ID: 31495543
[TBL] [Abstract][Full Text] [Related]
4. Prevention of variceal rebleeding and treatment of liver carcinoma by consecutive transjugular intrahepatic portosystemic shunt and hepatic artery chemoembolization.
Nicolini A; Saccheri S; Lovaria A; Maggi A; Cazzaniga M; Panzeri A; Salerno F
Ital J Gastroenterol; 1996 Jun; 28(5):269-71. PubMed ID: 8842845
[TBL] [Abstract][Full Text] [Related]
5. Reply letter to "The incidence and predictors of post transarterial chemoembolization variceal bleeding in hepatocellular carcinoma patients: Bystander rather than offender".
Lin PT; Teng W; Jeng WJ; Lin CY
J Formos Med Assoc; 2020 Oct; 119(10):1564-1565. PubMed ID: 32513505
[No Abstract] [Full Text] [Related]
6. The incidence and predictors of post transarterial chemoembolization variceal bleeding in hepatocellular carcinoma patients: Bystander rather than offender.
Cheng TH; Wang CC
J Formos Med Assoc; 2020 Oct; 119(10):1562-1563. PubMed ID: 32517966
[No Abstract] [Full Text] [Related]
7. Risk factors for esophageal variceal bleeding in patients with hepatocellular carcinoma.
Akanuma M; Yoshida H; Okamoto M; Ogura K; Maeda S; Hata Y; Sato S; Shiina S; Kawabe T; Shiratori Y; Omata M
Hepatogastroenterology; 2002; 49(46):1039-44. PubMed ID: 12143197
[TBL] [Abstract][Full Text] [Related]
8. Injection sclerotherapy for variceal bleeding in patients with irresectable hepatocellular carcinoma.
Letier MH; Krige JE; Lemmer ER; Terblanche J
Hepatogastroenterology; 2000; 47(36):1680-4. PubMed ID: 11149031
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of patients with hepatocellular carcinoma presenting with variceal bleeding.
Lang BH; Poon RT; Fan ST; Wong J
Am J Gastroenterol; 2004 Nov; 99(11):2158-65. PubMed ID: 15554997
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal: esophageal metastasis from hepatocellular carcinoma.
Fukatsu H; Miura S; Kishida H; Takagi S; Morishita H; Uchino K; Fujisawa M
J Gastroenterol Hepatol; 2012 Sep; 27(9):1536. PubMed ID: 22908871
[No Abstract] [Full Text] [Related]
11. Clinical significance and prediction factors of gastric varices in patients with hepatocellular carcinoma.
Yeh JL; Peng YC; Tung CF; Yang DY; Hu WH; Chow WK; Yeh HZ; Chen GH
Hepatogastroenterology; 2003; 50(53):1603-8. PubMed ID: 14571795
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological therapy alone or in combination with endoscopic therapy for acute variceal bleeding in hepatocellular carcinoma.
Peng Z; Liu L; Han B; Zhou X; Guo X; Qi X
Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1530-1531. PubMed ID: 30395016
[No Abstract] [Full Text] [Related]
13. Gastroesophageal Variceal Bleeding Successfully Controlled by Partial Splenic Embolization.
Kogure T; Inoue J; Kakazu E; Ninomiya M; Shimosegawa T
Intern Med; 2017; 56(11):1339-1343. PubMed ID: 28566595
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma with portal vein tumor thrombus.
Sniderman KW
Radiology; 1998 May; 207(2):552-3. PubMed ID: 9577511
[No Abstract] [Full Text] [Related]
15. A prospective study of upper gastrointestinal hemorrhage in patients with hepatocellular carcinoma.
Yeo W; Sung JY; Ward SC; Chung SC; Lee WY; Li AK; Johnson PJ
Dig Dis Sci; 1995 Dec; 40(12):2516-21. PubMed ID: 8536505
[TBL] [Abstract][Full Text] [Related]
16. Injection sclerotherapy for bleeding esophageal varices in cirrhotic patients with hepatocellular carcinoma.
Ng WD; Chan YT; Ho KK; Kong CK
Gastrointest Endosc; 1989; 35(1):69-70. PubMed ID: 2537777
[No Abstract] [Full Text] [Related]
17. Long-term risk factors for bleeding after first course of endoscopic injection sclerotherapy: a univariate and multivariate analysis.
Kokawa H; Shijo H; Kubara K; Nakaoka K; Toriya H; Shirai Z; Okazaki M
Am J Gastroenterol; 1993 Aug; 88(8):1206-11. PubMed ID: 8393274
[TBL] [Abstract][Full Text] [Related]
18. Development of hepatocellular carcinoma after successful management of esophageal variceal bleeding.
Chen WC; Lo GH; Lai KH; Cheng JS; Hsu PI; Lin CK
J Chin Med Assoc; 2004 Nov; 67(11):557-64. PubMed ID: 15720069
[TBL] [Abstract][Full Text] [Related]
19. Injection sclerotherapy for variceal bleeding in patients with hepatocellular carcinoma: cyanoacrylate versus sodium tetradecyl sulphate.
Sung JJ; Yeo W; Suen R; Lee YT; Chung SC; Chan FK; Johnson PJ
Gastrointest Endosc; 1998 Mar; 47(3):235-9. PubMed ID: 9540875
[TBL] [Abstract][Full Text] [Related]
20. Predictors of in-hospital mortality after acute variceal bleeding in patients with hepatocellular carcinoma and concurrent main portal vein thrombosis.
Han ML; Chen CC; Kuo SH; Hsu WF; Liou JM; Wu MS; Wang HP
J Gastroenterol Hepatol; 2014 Feb; 29(2):344-51. PubMed ID: 23870023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
